Tekturna HCT Related Published Studies
Well-designed clinical trials related to Tekturna HCT (Aliskiren / Hydrochlorothiazide)
Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study. [2011.10.01]
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. [2011.05]
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. [2011.03]
Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study. [2010.12]
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone. [2009.04]
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. [2008.12]
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. [2008.03]
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. [2007.10]
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension. [2007.05]
Aliskiren, an orally effective Renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. [2007.01]
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. [2007.01]
Other research related to Tekturna HCT (Aliskiren / Hydrochlorothiazide)
Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino
patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or
in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to
Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy). [2012]
Pharmacokinetics and pharmacodynamics of aliskiren/hydrochlorothiazide
single-pill combination tablets and free combination of aliskiren and
hydrochlorothiazide. [2012]
Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus. [2011.12]
Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg. [2011.11.28]
Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide. [2011.06.09]
Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (+/- amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg. [2011.01]
Efficacy of aliskiren/hydrochlorothiazide combination for the treatment of hypertension: a meta-analytical approach. [2011]
Peripheral and central blood pressure responses of combination
aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American
patients with stage 2 hypertension: the ATLAAST trial. [2011]
Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension. [2010.12]
[Advances concerning aliskiren, direct renin inhibitor and aliskiren-hydrochlorothiazide] [2009.11]
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension. [2009.04]
Transdermal oxybutynin. [2009]
Aliskiren. [2008.07.15]
Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis. [2008.04]
Renin inhibition with aliskiren. [2008.04]
Aliskiren-hydrochlorothiazide combination for the treatment of hypertension. [2008.03]
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. [2008]
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. [2008]
Aliskiren: an oral renin inhibitor for the treatment of hypertension. [2007.11]
Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren. [2007.09]
[Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?] [2007.04]
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. [2007.02]
Selegiline transdermal system: in the treatment of major depressive disorder. [2007]
The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension. [2007]
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. [2006.11]
Other possibly related research studies
Gateways to clinical trials. [2008.01]
Gateways to clinical trials. [2007.11]
Gateways to clinical trials. [2007.09]
Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2007]
Renin inhibition: a new modality for hypertension management. [2007.08]
Gateways to clinical trials. [2007.04]
Gateways to clinical trials. [2006.10]
Gateways to Clinical Trials. [2002.09]
|
